Global Coagulation Factor IX Market Growth 2025-2031
Description
The global Coagulation Factor IX market size is predicted to grow from US$ 406 million in 2025 to US$ 577 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Coagulation Factor IX Industry Forecast” looks at past sales and reviews total world Coagulation Factor IX sales in 2024, providing a comprehensive analysis by region and market sector of projected Coagulation Factor IX sales for 2025 through 2031. With Coagulation Factor IX sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coagulation Factor IX industry.
This Insight Report provides a comprehensive analysis of the global Coagulation Factor IX landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coagulation Factor IX portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coagulation Factor IX market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coagulation Factor IX and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coagulation Factor IX.
This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor IX market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segmentation by Application:
Adult
Kids
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Coagulation Factor IX market?
What factors are driving Coagulation Factor IX market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coagulation Factor IX market opportunities vary by end market size?
How does Coagulation Factor IX break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Coagulation Factor IX Industry Forecast” looks at past sales and reviews total world Coagulation Factor IX sales in 2024, providing a comprehensive analysis by region and market sector of projected Coagulation Factor IX sales for 2025 through 2031. With Coagulation Factor IX sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Coagulation Factor IX industry.
This Insight Report provides a comprehensive analysis of the global Coagulation Factor IX landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Coagulation Factor IX portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Coagulation Factor IX market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Coagulation Factor IX and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Coagulation Factor IX.
This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor IX market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segmentation by Application:
Adult
Kids
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Coagulation Factor IX market?
What factors are driving Coagulation Factor IX market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Coagulation Factor IX market opportunities vary by end market size?
How does Coagulation Factor IX break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
89 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Coagulation Factor IX by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Coagulation Factor IX by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
